Vascepa is a prescription drug used to lower high triglyceride levels in adults. The drug is manufactured by Amarin Corporation and was approved by the FDA in 2012. The cost of Vascepa can be high, and patients may wonder if their insurance plans cover the drug.

According to the Vascepa website [2], the drug is covered by most commercial insurance plans. However, the extent of coverage may vary depending on the specific plan and the patient's individual benefits. Patients are advised to check with their insurance provider to determine their coverage.

DrugPatentWatch [1] provides information on the patent status of Vascepa but does not provide information on insurance coverage. However, SingleCare [3] notes that patients without insurance may be able to access discounts through the manufacturer's patient assistance program or through pharmacy discount programs.

In conclusion, Vascepa is generally covered by most commercial insurance plans, but patients should check with their specific provider to determine their coverage. Patients without insurance may be able to access discounts through the manufacturer's patient assistance program or through pharmacy discount programs.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.vascepahcp.com/access-and-coverage/
[3] https://www.singlecare.com/blog/vascepa-without-insurance/